Cooper Companies | COO - Gross Profit On Sales

Stock Price
61.44
Daily Change
0.50 0.82%
Monthly
-11.55%
Yearly
-24.61%
Q2 Forecast
58.41

Cooper Companies reported $695.2M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
AtriCure USD 109.31M 3.97M Mar/2026
Avanos Medical USD 94.2M 8.2M Mar/2026
Bausch Health Companies USD 2B 67M Dec/2025
Baxter International USD 891M 314M Mar/2026
Bayer EUR 6.94B 1.58B Dec/2025
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Cooper Companies USD 695.2M 44.4M Dec/2025
Dentsply International USD 427M 16M Mar/2026
Dexcom USD 750.3M 42.4M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Globus Medical USD 496.26M 39.69M Mar/2026
Haemonetics USD 202.39M 7.64M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 540.8M 27.8M Mar/2026
Integra LifeSciences USD 213.21M 3.89M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
J&J USD 17.24B 642M Mar/2026
Medtronic USD 5.41B 27M Dec/2025
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Novartis USD 10.82B 694M Sep/2025
ResMed USD 890.98M 12.26M Mar/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Steris USD 655.5M 9.6M Dec/2025
Stryker USD 3.81B 675M Mar/2026
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Utah Medical Products USD 5.8M 450K Sep/2024
Zimmer Biomet Holdings USD 1.27B 8.1M Dec/2025